1World Health Organization. The world health report 2001 - Mental health: new understanding, new hope[R]. Geneva: World Health Organization,2001.
2Maes M, Yirmyia R, Noraberg J, et al. The inflammatory neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression[J]. Metab Brain Dis, 2009,24 (1) : 27- 53.
3Dowlati Y, Herrmann N, Swardfager W, et al. A meta- analysis of cytokines in major depression[J]. Biol Psychiatry, 2010,67(5) :446-457,.
4Dean OM, Maes M, Ashton M, et al. Protocol and rationale- the efficacy of minocyeline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial[J]. Clin Psychopharmacol Neurosei,2014,12(3): 180-188.
5Zunszain PA, Hepgul N, Patiante CM. Inflammation and depression[J]. Curr Top Behav Neurosci, 2013,14 : 135- 151.
6Horowitz MA, Zunszain PA. Neuroimmune and neuroendo crine abnormalities in depression: two sides of the same coin [J]. AnnNYAcadSci,2015,1351:68-79.
7Maes M, Vandoolaeghe E, Ranjan R, et al. Increased serum interleukin- 1 - receptor- antagonist concentrations in major depression[J]. J Affect Disord, 1995,36 ( 1/2) : 29 - 36.
8Kern S, Skoog I, Borjesson- Hanson A, et al. Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years[J]. Brain Behav Immun, 2013,32:153-158.
9Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation:depression fans the flames and feasts on the heat[J]. Am J Psychiatry, 2015,17201) : 1 075- 1 091.
10Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression[J]. Psychol Bull, 2014,140(3) :774-815.
二级参考文献33
1David S, Aguayo AJ. Axonal elongation into peripheral nervous sys- tem "bridges" after central nervous system injury in adult rats [J]. Science, 1981, 214(4523): 931-933.
2McGee AW, Strittmatter SM. The Nogo-66 receptor:focusing my- elin inhibition of axon regeneration [J]. Trends Neurosci, 2003, 26 (4): 193-198.
3Madaule P, Axel R. A novel ms-related gene family [J]. Cell, 1985, 41(I): 31-40.
4Leung T, Manser E, Tan L, et al. A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the ki- nase to peripheral membranes [J]. Biol Chem, 1995, 270(49): 29051-29054.
5Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behav- iour [J]. Nat Rev Mol Cell Biol, 2003, 4(6): 446-456.
6Wettschureck N, Offermanns S. Rho/Rho-kinase mediated signaling in physiology and pathophysiology [J]. J Mol Med, 2002, 80(10): 629-638.
7Zhou Y, Su Y, Li B, et al. Nonsteroidal anti-inflammatory drugs can lower amyloidogenie Abeta42 by inhibiting Rho [J]. Science, 2003, 302(5648): 1215-1217.
8Breitner JC, Baker LD, Montine T J, et al. Extended results of the AI- zheimer's disease anti-inflammatory prevention trial [J]. Alzheimers Dement, 2011, 7(4): 402-411.
9Qiao Fu, Jeongsim Hue, Shuxin Li. Nonsteroidal Anti-Inflammatory Drugs Promote Axon Regeneration via RhoA Inhibition [J]. The Journal of Neuroscience, 2007, 27(15): 4154-4164.
10C~tmara-Lemarroy CR, Guzm~n-de la Garza F J, Barrera-Oranday EA, et al. Celecoxib accelerates functional recovery after sciatic nerve crush in the rat [J]. J Brachial Plex Peripher Nerve Inj, 2008, 3: 25.
